Yongjian Liu Selected Research

CC Chemokines

1/2024	Ketosis prevents abdominal aortic aneurysm rupture through C-C chemokine receptor type 2 downregulation and enhanced extracellular matrix balance.
6/2023	Ketosis Prevents Abdominal Aortic Aneurysm Rupture Through C-C Chemokine Receptor Type 2 Downregulation and Enhanced MMP Balance.
2/2023	Ketosis Prevents Abdominal Aortic Aneurysm Rupture Through CCR2 Downregulation and Enhanced MMP Balance.
1/2021	Resident cardiac macrophages mediate adaptive myocardial remodeling.
4/2016	Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT.
3/2016	⁶⁴Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongjian Liu Research Topics

Disease

37	Neoplasms (Cancer) 01/2024 - 04/2012
18	Atherosclerosis 03/2024 - 01/2010
17	Inflammation (Inflammations) 01/2024 - 06/2013
6	Abdominal Aortic Aneurysm 01/2024 - 01/2020
6	Rupture 01/2024 - 01/2020
6	Fibrosis (Cirrhosis) 12/2023 - 01/2021
5	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2010
4	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2016
4	Myocardial Infarction 01/2024 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2016
4	Infections 01/2022 - 11/2015
4	Poisoning 03/2021 - 04/2015
4	Disease Progression 01/2021 - 04/2014
4	Weight Gain 01/2018 - 01/2016
4	Vascular System Injuries 01/2017 - 07/2013
3	COVID-19 01/2024 - 01/2021
3	Ketosis 01/2024 - 02/2023
3	Heart Diseases (Heart Disease) 11/2023 - 10/2021
3	Body Weight (Weight, Body) 03/2023 - 04/2020
3	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2023 - 09/2021
3	Hypoxia (Hypoxemia) 05/2020 - 10/2013
3	Catalepsy 02/2018 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 11/2014 - 02/2013
2	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2018
2	Adenocarcinoma 01/2024 - 01/2021
2	Heart Failure 12/2023 - 01/2021
2	Myocarditis (Carditis) 09/2023 - 04/2023
2	Carotid Artery Diseases 03/2023 - 08/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2022
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 03/2011
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 05/2002
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 01/2012
2	Aneurysm (Aneurysms) 09/2020 - 09/2017
2	Triple Negative Breast Neoplasms 01/2019 - 03/2016
2	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
2	Glioma (Gliomas) 09/2017 - 09/2015
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2017 - 05/2016
2	Lung Injury 02/2017 - 01/2017
2	Neointima 01/2017 - 01/2010
1	Hypothermia 02/2024

Drug/Important Bio-Agent (IBA)

14	Chemokine ReceptorsIBA 01/2024 - 07/2013
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2014
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2016
10	Apolipoproteins E (ApoE)IBA 07/2023 - 07/2013
9	GoldIBA 01/2022 - 07/2012
7	Peptides (Polypeptides)IBA 05/2022 - 01/2015
6	CC ChemokinesIBA 01/2024 - 03/2016
6	ApolipoproteinsIBA 01/2021 - 07/2013
6	Natriuretic PeptidesIBA 05/2019 - 01/2010
5	ChemokinesIBA 02/2024 - 07/2013
5	AntibodiesIBA 09/2023 - 01/2015
4	AminopropionitrileIBA 01/2024 - 01/2020
4	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 01/2023
4	LipidsIBA 03/2023 - 01/2022
4	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 04/2016
4	CopperIBA 01/2021 - 01/2019
3	Ketone BodiesIBA 01/2024 - 02/2023
3	Pancreatic Elastase (Elastase)IBA 01/2024 - 02/2023
3	Monocyte Chemoattractant ProteinsIBA 01/2024 - 02/2023
3	Messenger RNA (mRNA)IBA 12/2023 - 03/2011
3	RNA (Ribonucleic Acid)IBA 09/2023 - 10/2017
3	CytokinesIBA 02/2023 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 05/2002
3	Atrial Natriuretic Factor (ANF)IBA 05/2019 - 01/2010
3	Phencyclidine (Angel Dust)IBA 02/2018 - 01/2016
3	ParaquatIBA 11/2017 - 04/2015
2	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2022
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 11/2023
2	p38 Mitogen-Activated Protein KinasesIBA 12/2023 - 01/2017
2	Immune Checkpoint InhibitorsIBA 09/2023 - 04/2023
2	CollagenIBA 02/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2015
2	AntioxidantsIBA 07/2022 - 05/2020
2	OligosaccharidesIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2015
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 01/2020
2	vMIP-IIIBA 01/2021 - 01/2016
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2021 - 04/2014
2	(64)Cu-DOTA-vMIP-IIIBA 01/2021 - 07/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 05/2002
2	Lipopolysaccharide ReceptorsIBA 11/2017 - 01/2017
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2017 - 01/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2016 - 10/2013
2	AmidesIBA 04/2016 - 03/2016
2	Radioisotopes (Radionuclides)IBA 04/2016 - 01/2015
2	Monoclonal AntibodiesIBA 01/2016 - 10/2013
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2016 - 01/2010
1	Cell Surface ReceptorsIBA 04/2024
1	Amyloid (Amyloid Fibrils)IBA 04/2024
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024

Therapy/Procedure

28	Therapeutics 01/2024 - 01/2012
6	Precision Medicine 11/2023 - 04/2012
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2017
2	Stents 09/2020 - 09/2017
2	Transplantation 01/2018 - 01/2018
2	Lung Transplantation 01/2018 - 01/2017
2	Highly Active Antiretroviral Therapy (HAART) 11/2015 - 01/2012